Evidence map›Paper›PMID 42270862›Full record

ArticleCurrent microbiology2026

Genomics of Hospital-Associated Brazilian Multidrug-Resistant Klebsiella pneumoniae: Abundance of Resistance and Virulence Genes and Mosaicism of the bla

Monalessa Fábia Pereira, Ciro César Rossi, Mirla Borghi, Beatriz Dias Januário, Ana Luisa Andrade-Oliveira, Denise Mara Soares Bazzolli, Luiz Gonzaga Paula de Almeida, Ana Tereza Ribeiro de Vasconcelos, Marisa Fabiana Nicolás, Ricardo Pinto Schuenck

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monalessa Fábia PereiraInstituto de Biodiversidade e Sustentabilidade, Universidade Federal do Rio de Janeiro, Macaé, RJ, Brazil. monalessapereira@ufrj.br.
Ciro César RossiDepartamento de Biologia Celular e Molecular, Universidade Federal Fluminense, Niterói, RJ, Brazil.
Mirla BorghiDepartamento de Patologia, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.
Beatriz Dias JanuárioDepartamento de Ciências Biológicas, Universidade do Estado de Minas Gerais, Carangola, MG, Brazil.
Ana Luisa Andrade-OliveiraInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Denise Mara Soares BazzolliDepartamento de Microbiologia, Universidade Federal de Viçosa, Viçosa, MG, Brazil.
Luiz Gonzaga Paula de AlmeidaLaboratório Nacional de Computação Científica, Petrópolis, RJ, Brazil.
Ana Tereza Ribeiro de VasconcelosLaboratório Nacional de Computação Científica, Petrópolis, RJ, Brazil.
Marisa Fabiana NicolásLaboratório Nacional de Computação Científica, Petrópolis, RJ, Brazil.
Ricardo Pinto SchuenckDepartamento de Patologia, Universidade Federal do Espírito Santo, Vitória, ES, Brazil. ricardo.schuenck@ufes.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a critical threat to global public health due to limited therapeutic options. This situation is magnified by CRKP strains with elevated virulence. This study aimed to characterize the virulome, resistome, and bla

Indexed as

beta-LactamasesCross InfectionDrug Resistance, Multiple, BacterialKlebsiella InfectionsKlebsiella pneumoniaeVirulence FactorsAnti-Bacterial AgentsBacterial ProteinsBrazilGenomicsHumansVirulenceAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesVirulence Factors

Identifiers

PMID42270862
PMCPMC13253593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.